ODIN is sponsored by The Novo Nordisk Foundation with 54,5 M DKK in a 3-year pilot. Within this period - until October 2023 - we aim to break down the barriers between industry and academia to support pre-competitive research in a collaborative, open environment without IP.

We seek to unite brilliant minds from both university and industry in open innovation projects, where participants together can build the knowledge foundations for better and faster drug discovery. 

On the pages below, you can read more about how it all works. If you still have questions, you are more than welcome to contact the ODIN secretariat.